Research ExplorerPublicationsCardioversion of atrial fibrillation and atrial flutter revi...

Cardioversion of atrial fibrillation and atrial flutter revisited: Current evidence and practical guidance for a common procedure

Standard

Cardioversion of atrial fibrillation and atrial flutter revisited: Current evidence and practical guidance for a common procedure. / Brandes, Axel; Crijns, Harry J.G.M.; Rienstra, Michiel; Kirchhof, Paulus; Grove, Erik L.; Pedersen, Kenneth Bruun; van Gelder, Isabelle C.

In: EUROPACE, Vol. 22, No. 8, 01.08.2020, p. 1149-1161.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Brandes, A, Crijns, HJGM, Rienstra, M, Kirchhof, P, Grove, EL, Pedersen, KB & van Gelder, IC 2020, 'Cardioversion of atrial fibrillation and atrial flutter revisited: Current evidence and practical guidance for a common procedure', EUROPACE, vol. 22, no. 8, pp. 1149-1161. https://doi.org/10.1093/europace/euaa057

APA

Brandes, A., Crijns, H. J. G. M., Rienstra, M., Kirchhof, P., Grove, E. L., Pedersen, K. B., & van Gelder, I. C. (2020). Cardioversion of atrial fibrillation and atrial flutter revisited: Current evidence and practical guidance for a common procedure. EUROPACE, 22(8), 1149-1161. https://doi.org/10.1093/europace/euaa057

Vancouver

Brandes A, Crijns HJGM, Rienstra M, Kirchhof P, Grove EL, Pedersen KB et al. Cardioversion of atrial fibrillation and atrial flutter revisited: Current evidence and practical guidance for a common procedure. EUROPACE. 2020 Aug 1;22(8):1149-1161. https://doi.org/10.1093/europace/euaa057

Bibtex

@article{3b729ea47ded40b48093bd037c3a39ed,
title = "Cardioversion of atrial fibrillation and atrial flutter revisited: Current evidence and practical guidance for a common procedure",
abstract = "Cardioversion is widely used in patients with atrial fibrillation (AF) and atrial flutter when a rhythm control strategy is pursued. We sought to summarize the current evidence on this important area of clinical management of patients with AF including electrical and pharmacological cardioversion, peri-procedural anticoagulation and thromboembolic complications, success rate, and risk factors for recurrence to give practical guidance.",
keywords = "Anticoagulation, Atrial fibrillation, Atrial flutter, Electrical cardioversion, Pharmacological cardioversion, Thromboembolism",
author = "Axel Brandes and Crijns, {Harry J.G.M.} and Michiel Rienstra and Paulus Kirchhof and Grove, {Erik L.} and Pedersen, {Kenneth Bruun} and {van Gelder}, {Isabelle C.}",
note = "Publisher Copyright: {\textcopyright} The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.",
year = "2020",
month = aug,
day = "1",
doi = "10.1093/europace/euaa057",
language = "English",
volume = "22",
pages = "1149--1161",
journal = "EUROPACE",
issn = "1099-5129",
publisher = "Oxford University Press",
number = "8",

}

RIS

TY - JOUR

T1 - Cardioversion of atrial fibrillation and atrial flutter revisited: Current evidence and practical guidance for a common procedure

AU - Brandes, Axel

AU - Crijns, Harry J.G.M.

AU - Rienstra, Michiel

AU - Kirchhof, Paulus

AU - Grove, Erik L.

AU - Pedersen, Kenneth Bruun

AU - van Gelder, Isabelle C.

N1 - Publisher Copyright: © The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

PY - 2020/8/1

Y1 - 2020/8/1

N2 - Cardioversion is widely used in patients with atrial fibrillation (AF) and atrial flutter when a rhythm control strategy is pursued. We sought to summarize the current evidence on this important area of clinical management of patients with AF including electrical and pharmacological cardioversion, peri-procedural anticoagulation and thromboembolic complications, success rate, and risk factors for recurrence to give practical guidance.

AB - Cardioversion is widely used in patients with atrial fibrillation (AF) and atrial flutter when a rhythm control strategy is pursued. We sought to summarize the current evidence on this important area of clinical management of patients with AF including electrical and pharmacological cardioversion, peri-procedural anticoagulation and thromboembolic complications, success rate, and risk factors for recurrence to give practical guidance.

KW - Anticoagulation

KW - Atrial fibrillation

KW - Atrial flutter

KW - Electrical cardioversion

KW - Pharmacological cardioversion

KW - Thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=85087726279&partnerID=8YFLogxK

U2 - 10.1093/europace/euaa057

DO - 10.1093/europace/euaa057

M3 - SCORING: Review article

C2 - 32337542

AN - SCOPUS:85087726279

VL - 22

SP - 1149

EP - 1161

JO - EUROPACE

JF - EUROPACE

SN - 1099-5129

IS - 8

ER -